← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2009Last known activity
Jul 2, 2025
Timeline
1990s
- Jan 1, 1997
Universitat Internacional de Catalunya— Founded
Drugs by trial phase (15 distinct, 9 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT06975345CollaboratorN/AJul 2, 2025
- NCT05536596Lead sponsorPhase 2/Phase 3Sep 30, 2022
- NCT05536596Reponsible party - principal investigatorPhase 2/Phase 3Sep 30, 2022
- NCT04705428Lead sponsorN/AJan 1, 2021
- NCT04705428Reponsible party - principal investigatorN/AJan 1, 2021
- NCT03574090Study directorPhase 4Jul 15, 2018
- NCT03574090Lead sponsorPhase 4Jul 15, 2018
- NCT03574090Reponsible party - principal investigatorPhase 4Jul 15, 2018
- NCT04677062Lead sponsorN/ANov 1, 2017
- NCT04677062Reponsible party - principal investigatorN/ANov 1, 2017
- NCT02602483CollaboratorPhase 1/Phase 2Dec 1, 2015
- NCT03047291Overall official - principal investigatorPhase 4Jan 1, 2014
- NCT03047291Reponsible party - principal investigatorPhase 4Jan 1, 2014
- NCT03047291Lead sponsorPhase 4Jan 1, 2014
- NCT02194023Overall official - principal investigatorPhase 2Sep 1, 2011
Details
- Founded
- Barcelona, ES Jan 1, 1997
- Last known activity
- Jul 2, 2025